Press releases
- ViiV Healthcare announces superior efficacy of investigational, long-acting injectable formulation of cabotegravir dosed every two months over daily oral PrEP
- GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine
- ViiV Healthcare presents positive data from first-ever implementation research study on how best to integrate an investigational once-monthly injectable HIV treatment in US healthcare practices
Tweets from GSK US
-
GSKUS @GSKUS
Ever wonder what it’s like to be a real #chemist? Join Julia from @TheFranklin as she guides students through our free #ScienceInTheSummer #STEM program. 👇#STEMKidss#GSKSISS
about 6 days ago -
GSKUS @GSKUS
#ScienceInTheSummer is virtual this year. Young students can learn to “Be a Chemist!” at home with our activity guides & videos. Experts from @TheFranklin will show kids how to safely set up a lab with simple household items & a notebook. 🧪🔬gsk.to/38ftGlrIX#GSKSiSSiS
about 13 days ago
-
GSKUS @GSKUS
At GSK, we support our LGBTQ+ colleagues and aim to be an ally against discrimination faced by members of the community. We’re committed to an inclusive workplace where everyone can be his/her/their best and most authentic selves. Happy #PrideMonth!
about 14 days ago
